ABR Atlas Panel

ABR Atlas Panel (RUO)

The A2K ABR Atlas Panel is a four-module multiplex qPCR panel built around allelic breadth: sixteen resistance targets that together cover sixty-seven sequence-confirmed alleles, including twenty-five carbapenemase alleles across Ambler classes A, B and D, five dfr determinants on a single channel, and the sul, qnr, ESBL, erm, van and mec determinants that change therapy in urinary tract and wound infection. A Bacillus atrophaeus internal control is included in every module. Allelic breadth was confirmed against 113 reference isolates from the CDC & FDA AR Isolate Bank and scored against whole-genome sequencing (298/300 positive agreement). For Research Use Only. Not for use in diagnostic procedures.

Explore the Atlas

Select Comprehensive or a single module to see which alleles it detects. Sixteen resistance targets across four multiplex modules cover sixty-seven confirmed alleles, and every module carries a Bacillus atrophaeus internal control on ATTO550. For Research Use Only. Not for use in diagnostic procedures.

Explore the panel

  • KPC-2
  • KPC-3
  • KPC-45
  • NDM-1
  • NDM-5
  • NDM-7
  • VIM-1
  • VIM-2
  • VIM-5
  • VIM-11
  • IMP-1
  • IMP-4
  • IMP-8
  • IMP-13
  • IMP-15
  • IMP-26
  • IMP-27
  • IMP-67
  • CTX-M-2
  • CTX-M-9
  • CTX-M-14
  • CTX-M-14b
  • CTX-M-15
  • CTX-M-55
  • SHV-1
  • SHV-11
  • SHV-12
  • SHV-27
  • SHV-28
  • SHV-99
  • SHV-100
  • SHV-105
  • SHV-187
  • TEM-1
  • TEM-1A
  • TEM-1B
  • TEM-1C
  • TEM-1D
  • OXA-1
  • OXA-23
  • OXA-48
  • OXA-58
  • OXA-181
  • OXA-232
  • OXA-244
  • OXA-371
  • sul1
  • sul2
  • dfrA1
  • dfrA5
  • dfrA8
  • dfrA17
  • dfrG
  • qnrA1
  • qnrB1
  • qnrB2
  • qnrB6
  • qnrB19
  • qnrS1
  • mecA
  • ermA
  • ermB
  • ermC
  • vanA
  • vanB
  • vanC1
  • tetM

Technical Specifications

SKU
Alleles listed
Reactions
Modules
Module composition
Mastermix
Optical channels
Internal Control
B. atrophaeus
Instrument Compatibility
QuantStudio 5, 6, 7, 12; Bio-Rad CFX Opus 96 & CFX96 Touch
Positive and negative percent agreement describe concordance with a sequence-derived genotype; they are not measures of clinical sensitivity or specificity and not a measure of susceptibility prediction. No claim of clinical sensitivity, clinical specificity, limit of detection or precision is made or implied, and no performance claim is made for any target beyond what is stated here. Alleles listed are those confirmed detected in the isolates tested to date; alleles not represented in these isolate sets have not been evaluated. This panel has not been cleared or approved by the FDA and has not been evaluated by the New York State Department of Health. Laboratories intending to test New York State specimens must obtain their own validation approval through the NYSDOH Clinical Laboratory Evaluation Program. For Research Use Only. Not for use in diagnostic procedures.

The ABR Atlas Panel protocol, coverage tables and isolate provenance are supplied with the panel. Contact Support@A2KScientific.com for a copy.

Instrument methods for this panel will be posted here.